Integration of UPLC-Q-Exactive MS/MS and in vivo studies to investigate the chemical composition and anti-diabetic nephropathy effects of polarity-based extracts from potentillae discoloris herba
Journal of Pharmaceutical and Biomedical Analysis · 2026-02 · 269 · 117239
DOI: 10.1016/j.jpba.2025.117239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-02. Verfasst von Yang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Hypoglycemic Agents, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Diabetic nephropathy (DN), a common and severe microvascular complication of type 2 diabetes mellitus, is characterized by lesions in the glomeruli and renal tubules. The various components of Potentillae Discoloris Herba (PDH) exhibit pharmacological activities, including anti-inflammatory and hypoglycemic effects. However, research on its chemical constituents and therapeutic potential for DN remains limited. This study aimed to investigate the chemical constituents of PDH using UPLC-Q-Exactive MS/MS, determine their distribution among different solvent-extracted fractions, and identify the key bioactive fractions and compounds responsible for hypoglycemic and renoprotective effects in DN. The ethanol extract of PDH was sequentially fractionated into petroleum ether, ethyl acetate, n-butanol, and aqueous fractions, with UPLC-MS/MS analysis revealing 90 compounds, primarily phenolic acids, flavonoids, and triterpenoids. In a DN rat model induced by high-fat/high-sugar diet and streptozotocin, the ethyl acetate fraction demonstrated rich chemical diversity and promising therapeutic effects, including reduced fasting blood glucose, improved lipid metabolism, attenuated renal dysfunction, and alleviated histopathological damage. Systematic phytochemical analysis demonstrated that phenolic acids and flavonoids are likely the key bioactive constituents underlying PDH's antidiabetic and renal protective properties. These findings enhance the understanding of PDH's chemical composition and pharmacological potential in DN treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
- Shandong College of Traditional Chinese Medicine, Yantai, Shandong 264199, China.
- The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250118, China.
- Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Electronic address: zhouhongleitcm@126.com.
Zitieren
APA
Wang, Y., Kong, X., Ni, L., Xiong, L., Cai, M., Kong, Q., Qu, Z., Shi, X., & Zhou, H. (2026). Integration of UPLC-Q-Exactive MS/MS and in vivo studies to investigate the chemical composition and anti-diabetic nephropathy effects of polarity-based extracts from potentillae discoloris herba. Journal of Pharmaceutical and Biomedical Analysis, 269, 117239. https://doi.org/10.1016/j.jpba.2025.117239
Vancouver
Wang Y, Kong X, Ni L, Xiong L, Cai M, Kong Q, et al. Integration of UPLC-Q-Exactive MS/MS and in vivo studies to investigate the chemical composition and anti-diabetic nephropathy effects of polarity-based extracts from potentillae discoloris herba. Journal of Pharmaceutical and Biomedical Analysis. 2026;269:117239. doi:10.1016/j.jpba.2025.117239
BibTeX
@article{Wang2026,
author = {Wang, Yang and Kong, Xiaoni and Ni, Linlin and Xiong, Lewen and Cai, Meichao and Kong, Qinghe and Qu, Zhizi and Shi, Xinyu and Zhou, Honglei},
title = {Integration of UPLC-Q-Exactive MS/MS and in vivo studies to investigate the chemical composition and anti-diabetic nephropathy effects of polarity-based extracts from potentillae discoloris herba},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
volume = {269},
pages = {117239},
doi = {10.1016/j.jpba.2025.117239}
}
EUVIMED